PL3709978T3 - Doustny preparat farmaceutyczny zawierający bakterie - Google Patents

Doustny preparat farmaceutyczny zawierający bakterie

Info

Publication number
PL3709978T3
PL3709978T3 PL18803675.0T PL18803675T PL3709978T3 PL 3709978 T3 PL3709978 T3 PL 3709978T3 PL 18803675 T PL18803675 T PL 18803675T PL 3709978 T3 PL3709978 T3 PL 3709978T3
Authority
PL
Poland
Prior art keywords
comrpsing
bacteria
oral formulation
pharmaceutical oral
pharmaceutical
Prior art date
Application number
PL18803675.0T
Other languages
English (en)
Inventor
Carole SCHWINTNER
Marianne Robin
Jean-François Dubuisson
Hervé AFFAGARD
Cédric Michenet
Amandine Bardy
Original Assignee
Maat Pharma
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maat Pharma, Biocodex filed Critical Maat Pharma
Publication of PL3709978T3 publication Critical patent/PL3709978T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL18803675.0T 2017-11-17 2018-11-16 Doustny preparat farmaceutyczny zawierający bakterie PL3709978T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17306602.8A EP3485879A1 (en) 2017-11-17 2017-11-17 Pharmaceutical oral formulation comrpsing bacteria
PCT/EP2018/081650 WO2019097030A1 (en) 2017-11-17 2018-11-16 Pharmaceutical oral formulation comprising bacteria

Publications (1)

Publication Number Publication Date
PL3709978T3 true PL3709978T3 (pl) 2023-10-02

Family

ID=60473460

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18803675.0T PL3709978T3 (pl) 2017-11-17 2018-11-16 Doustny preparat farmaceutyczny zawierający bakterie

Country Status (19)

Country Link
US (1) US11141440B2 (pl)
EP (2) EP3485879A1 (pl)
JP (1) JP7253546B2 (pl)
KR (1) KR102742180B1 (pl)
CN (1) CN111343972B (pl)
AU (1) AU2018367230B2 (pl)
CA (1) CA3079627C (pl)
DK (1) DK3709978T3 (pl)
ES (1) ES2947578T3 (pl)
FI (1) FI3709978T3 (pl)
HR (1) HRP20230647T1 (pl)
HU (1) HUE062579T2 (pl)
IL (1) IL273740B2 (pl)
LT (1) LT3709978T (pl)
PL (1) PL3709978T3 (pl)
PT (1) PT3709978T (pl)
RS (1) RS64290B1 (pl)
SI (1) SI3709978T1 (pl)
WO (1) WO2019097030A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7624449B2 (ja) * 2019-10-07 2025-01-30 シオルタ・セラピューティクス,インコーポレイテッド 治療用医薬組成物
CN111413503A (zh) * 2020-03-28 2020-07-14 浙江大学 骨桥蛋白作为靶分子在调节高脂饮食引起的肥胖中的应用
EP3895716A1 (en) 2020-04-17 2021-10-20 Maat Pharma Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients
CN111690044B (zh) * 2020-05-06 2022-03-01 中南大学湘雅二医院 Amuc1100蛋白的用途
WO2022055871A1 (en) * 2020-09-11 2022-03-17 California Institute Of Technology Probiotic treatments for parkinson's disease
JP2024501818A (ja) 2020-12-23 2024-01-16 マー ファルマ 微生物の複合群集を増殖させる方法
CN112826836A (zh) * 2021-01-08 2021-05-25 深圳未知君生物科技有限公司 一种粪菌口服制剂及其制备方法
CA3223776A1 (en) * 2021-07-09 2023-01-12 Evonik Operations Gmbh Hard shell capsules having improved colon release
CN116531411A (zh) * 2022-01-26 2023-08-04 锦乔生物科技有限公司 使用乳酸菌菌株组合来提升肠胃道屏障功能
CN121712489A (zh) * 2023-08-15 2026-03-20 赢创运营有限公司 一种用于在回肠和结肠递送剂型的肠溶包衣硬壳胶囊
WO2025141323A1 (en) * 2023-12-29 2025-07-03 Maat Pharma Compositions used in combination with immune modulatory treatments for treating cancers
CN117603884B (zh) * 2024-01-17 2024-03-26 广州同康生物科技有限公司 一种嗜黏蛋白阿克曼氏菌菌粉及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
CN101801356B (zh) * 2007-09-21 2016-10-19 赢创罗姆有限公司 耐受乙醇影响的非阿片类的pH依赖性受控释放的药物组合物
CN104918624A (zh) * 2012-11-26 2015-09-16 托马斯·朱利叶斯·波洛迪 恢复排泄物微生物群的组合物及其制造和使用方法
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
IL251844B2 (en) 2014-10-23 2024-04-01 Roussy Inst Gustave Methods and products for modulating microbiota composition for improving the efficacy of a cancer treatment with an immune checkpoint blocker
CN104490848B (zh) * 2014-12-31 2018-01-30 四川峨嵋山药业有限公司 一种雷替曲塞结肠定位微丸及其制备方法
FR3035328B1 (fr) 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
PL3307289T3 (pl) 2015-06-09 2022-01-17 Rebiotix, Inc. Sposoby wytwarzania kompozycji do terapii przywracającej mikrobiotę (mrt)
FR3045383B1 (fr) 2015-12-18 2019-06-14 Maat Pharma Procede de lyophilisation d'un echantillon de microbiote fecal

Also Published As

Publication number Publication date
IL273740A (en) 2020-05-31
KR20200088395A (ko) 2020-07-22
IL273740B1 (en) 2023-12-01
CA3079627A1 (en) 2019-05-23
SI3709978T1 (sl) 2023-09-29
AU2018367230B2 (en) 2023-06-08
HUE062579T2 (hu) 2023-11-28
IL273740B2 (en) 2024-04-01
LT3709978T (lt) 2023-08-10
HRP20230647T1 (hr) 2023-09-29
EP3709978B8 (en) 2023-05-31
WO2019097030A1 (en) 2019-05-23
PT3709978T (pt) 2023-07-11
EP3485879A1 (en) 2019-05-22
CN111343972A (zh) 2020-06-26
JP2021503452A (ja) 2021-02-12
EP3709978B1 (en) 2023-04-05
US20200345790A1 (en) 2020-11-05
JP7253546B2 (ja) 2023-04-06
CN111343972B (zh) 2022-10-28
CA3079627C (en) 2023-06-13
ES2947578T3 (es) 2023-08-11
FI3709978T3 (fi) 2023-06-28
RS64290B1 (sr) 2023-07-31
US11141440B2 (en) 2021-10-12
DK3709978T3 (da) 2023-06-12
KR102742180B1 (ko) 2024-12-11
AU2018367230A1 (en) 2020-05-07
EP3709978A1 (en) 2020-09-23

Similar Documents

Publication Publication Date Title
IL273740A (en) Oral pharmaceutical formulation containing bacteria
GB201807942D0 (en) Pharmaceutical formulation
ZA201903101B (en) Pharmaceutical formulations
IL278927A (en) pharmaceutical preparation
IL271226A (en) medical preparation
IL290894A (en) pharmaceutical preparation
PT3426294T (pt) Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina
ZA202102871B (en) Pharmaceutical formulation
IL266537A (en) pharmaceutical preparation
SG11202010124SA (en) Stable pharmaceutical formulation
ZA202006570B (en) Pharmaceutical formulations
IL262204A (en) Granular formulation for oral administration
PL3793609T3 (pl) Preparat w postaci doustnego roztworu
ZA201807851B (en) Pharmaceutical formulation
PL3601277T3 (pl) Preparat farmaceutyczny
IL275144A (en) Pharmacy preparation
IL271908A (en) Over-compressed pharmaceutical preparations
GB201906473D0 (en) Pharmaceutical formulation
SG11202003098WA (en) Oral bendamustine formulations
EP3512507A4 (en) ORAL MEDICINAL FORMULATIONS
EP3880171C0 (en) IBUPROFEN CONTAINING ORAL PHARMACEUTICAL FORMULATION
GB201719873D0 (en) Pharmaceutical formulation
GB201610440D0 (en) Pharmaceutical formulations
HUE052455T2 (hu) Szilibin-tartalmú orális gyógyszerkészítmény
GB201604545D0 (en) Novel pharmaceutical formulation